Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Medivitan
- Development stage
- Phase 4
- Lead developer
- Medice
- Modality
- Small Molecules
- Administration
- Intravenous, Intramuscular
01
Overview
**Medivitan** is a brand name for an injectable combination therapy containing **pyridoxine hydrochloride (vitamin B6)**, **cyanocobalamin (vitamin B12)**, and **folic acid (vitamin B9)**, developed by MEDICE Arzneimittel Pütter GmbH & Co. KG for treating combined deficiencies of these vitamins that cannot be corrected by diet alone. It is primarily indicated for pernicious anemia, megaloblastic anemia, vitamin B6/B12/folic acid deficiencies, and related symptoms like fatigue, loss of energy, and dietary deficiencies due to malabsorption; the intravenous or intramuscular administration ensures 100% bioavailability, providing rapid revitalization often noticeable after the first dose with effects lasting months.[1][3][4][5]
- Brand names
- MedivitanMedivitan iVMedivitan iM
- Other names
- pyridoxine hydrochloride + cyanocobalamin + folic acid
02
Targets
GART (GAR transformylase)MMUT (Methylmalonyl-coenzyme A mutase)MTR (Methionine synthase)
Beyond the preview
Go deeper on Medivitan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Medivitan.